1. DNA methyltransferases in hematological malignancies
   Nguyet-Minh Hoang et al, 2020, Journal of Genetics and Genomics CrossRef
2. Insight into the potential candidate genes and signaling pathways involved in lymphoma disease in dogs using a comprehensive whole blood transcriptome analysis
   Sunirmal Sheet et al, 2022, Gene CrossRef
3. Effect of titanium dioxide nanoparticles on DNA methylation in multiple human cell lines
   Marta Pogribna et al, 2020, Nanotoxicology CrossRef
4. JAK/STAT blockade reverses the malignant phenotype of Hodgkin and Reed-Sternberg cells
   Sara Fernández et al, 2023, Blood Advances CrossRef
5. Analyses of Transcriptomics Cell Signalling for Pre-Screening Applications in the Integrated Approach for Testing and Assessment of Non-Genotoxic Carcinogens
   Yusuke Oku et al, 2022, International Journal of Molecular Sciences CrossRef
6. DNA Methylation–Targeted Drugs
   Elodie M. Da Costa et al, 2017, The Cancer Journal CrossRef
7. Targeting the cancer epigenome: synergistic therapy with bromodomain inhibitors
   Mahalakshmi Ramadoss et al, 2018, Drug Discovery Today CrossRef
8. Exposure to a Titanium Dioxide Product Alters DNA Methylation in Human Cells
   Carlos Wells et al, 2024, Nanomaterials CrossRef
9. Profibrotic effect of IL-17A and elevated IL-17RA in idiopathic pulmonary fibrosis and rheumatoid arthritis-associated lung disease support a direct role for IL-17A/IL-17RA in human fibrotic interstitial lung disease
   Jie Zhang et al, 2019, American Journal of Physiology-Lung Cellular and Molecular Physiology CrossRef
10. Janus Kinase Signaling: Oncogenic Criminal of Lymphoid Cancers
    Boheng Li et al, 2021, Cancers CrossRef
11. Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with stage III or IV pancreatic ductal adenocarcinoma
    Benjamin E. Stubbe et al, 2023, Pancreatology CrossRef
12. Emerging epigenetic-modulating therapies in lymphoma
    David Sermer et al, 2019, Nature Reviews Clinical Oncology CrossRef
13. SMAD1 promoter hypermethylation and lack of SMAD1 expression in Hodgkin lymphoma: a potential target for hypomethylating drug therapy
    null Magdalena M. Gerlach et al, 2020, Haematologica CrossRef
14. New molecular targets in Hodgkin and Reed-Sternberg cells
    Hummaira Sadaf et al, 2023, Frontiers in Immunology CrossRef
15. Diminished expression of 5hmc in Reed-Sternberg cells in classical Hodgkin lymphoma is a common epigenetic marker
    Andrew Siref et al, 2020, Leukemia Research CrossRef
16. Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with localized pancreatic ductal adenocarcinoma
    Benjamin Emil Stubbe et al, 2023, Frontiers in Oncology CrossRef